Back to Search Start Over

Chemoimmunotherapy may not be dead yet in chronic lymphocytic leukemia, but fludarabine plus cyclophosphamide plus rituximab is potentially facing life support.

Authors :
Hawkes E.A.
Opat S.
Hawkes E.A.
Opat S.
Publication Year :
2018

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1305131514
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details